Description
The L272 monoclonal antibody specifically recognizes CD26 which is also known as Dipeptidyl peptidase IV (DPP IV), a serine protease. CD26 is a ~120 kDa type II transmembrane glycoprotein that is encoded by DPP4 and belongs to the DPP4 activity and/or structure homologue (DASH) protein family. It is associated with the binding of the TAT transactivating protein of the HIV. CD26 and CD45 act in a costimulatory fashion on T lymphocytes. Present on peripheral blood T lymphocytes, the CD26 antigen is upregulated on phytohemagglutinin (PHA) and concanavalin A (Con A)-stimulated peripheral blood mononuclear cells (PBMCs). The CD26 antigen is found on approximately 50% of CD4 and approximately 30% of CD8 cells. It is also found on some mature thymocytes, B cells, natural killer (NK) cells, monocytes, macrophages, epithelial cells, EBV transformed B-cell lines, and hairy cell leukemia. Absolute numbers of CD4+CD26+ and CD8+CD26+ cells are reported to be lower in HIV-positive individuals. The CD26-CD4+ cell appears to be a reservoir for HIV. CD26 bright CD4 lymphocytes are CD25+ and CD45RO+ memory T lymphocytes. The CD26 antigen can serve as a receptor for the coronavirus, MERS-CoV.
BD® CompBeads can be used as surrogates to assess fluorescence spillover (compensation). When fluorochrome conjugated antibodies are bound to BD® CompBeads, they have spectral properties very similar to cells. However, for some fluorochromes there can be small differences in spectral emissions compared to cells, resulting in spillover values that differ when compared to biological controls. It is strongly recommended that when using a reagent for the first time, users compare the spillover on cells and BD® CompBeads to ensure that BD® CompBeads are appropriate for your specific cellular application.
Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated to the dye under optimum conditions that minimize unconjugated dye and antibody.
1. Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.
2. Please refer to http://regdocs.bd.com to access safety data sheets (SDS).
3. For U.S. patents that may apply, see bd.com/patents.
4. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
5. Since applications vary, each investigator should titrate the reagent to obtain optimal results.
6. The production process underwent stringent testing and validation to assure that it generates a high-quality conjugate with consistent performance and specific binding activity. However, verification testing has not been performed on all conjugate lots.
7. Please observe the following precautions: We recommend that special precautions be taken (such as wrapping vials, tubes, or racks in aluminum foil) to protect exposure of conjugated reagents, including cells stained with those reagents, to any room illumination. Absorption of visible light can significantly affect the emission spectra and quantum yield of tandem fluorochrome conjugates.
8. For fluorochrome spectra and suitable instrument settings, please refer to our Multicolor Flow Cytometry web page at www.bdbiosciences.com/colors.
9. An isotype control should be used at the same concentration as the antibody of interest.
10. CF™ is a trademark of Biotium, Inc.
11. Human donor specific background has been observed in relation to the presence of anti-polyethylene glycol (PEG) antibodies, developed as a result of certain vaccines containing PEG, including some COVID-19 vaccines. We recommend use of BD Horizon Brilliant™ Stain Buffer in your experiments to help mitigate potential background. For more information visit https://www.bdbiosciences.com/en-us/support/product-notices.
